NasdaqCM - Delayed Quote USD

Bellevue Life Sciences Acquisition Corp. (BLACW)

Compare
0.0255
-0.0048
(-15.84%)
As of January 24 at 4:00:00 PM EST. Market Open.
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-1,964.5330
-818.7660
-4.2350
-0.4610
Investing Cash Flow
53,312.3050
-33,829.8150
--
--
Financing Cash Flow
-51,393.4910
34,539.4990
123.9790
-57.4350
End Cash Position
12.2360
15.4190
124.5010
4.7570
Income Tax Paid Supplemental Data
478.2060
16.2490
--
--
Issuance of Capital Stock
--
63,970.0000
--
--
Issuance of Debt
1,578.0000
--
800.0000
100.0000
Repayment of Debt
--
-1,200.0000
--
--
Repurchase of Capital Stock
-53,041.4910
-35,995.7280
--
--
Free Cash Flow
-1,964.5330
-818.7660
-4.2350
-0.4610
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers